**First ever full version Augmented reality app replicating a Human Liver**,
India’s first ever 3D Liver App! Free of cost, easy to navigate and user friendly!
This free app enables Health Care Practitioners (HCPs) to educate the patients on different stages of liver diseases with the help of a printed marker.
The prevalence of Non-Alcoholic Fatty Liver Disease (NAFLD) in India is around 9-35%¹. Globally liver disease is one of the leading causes of death.
- First of its kind innovative in clinic awareness tool
- Facilitates doctor patient interaction on NAFLD and enhances interest in the same
- Enables HCPs to guide patients on early detection, diagnosis and management of NAFLD
- Prevents the disease progression and enables the patients to live a healthy and happy life
This app is meant for HCPs and works only by scanning the Marker given by Abbott India Limited representatives to doctors.
Contact Abbott India Limited representative (WH & GI Team) to get the marker for the app to function.
¹ Duseja A, et al. Non-alcoholic Fatty Liver Disease and Metabolic Syndrome—Position Paper of the Indian National Association for the Study of the Liver, Endocrine Society of India, Indian College of Cardiology and Indian Society of Gastroenterology. J CLIN EXP HEPATOL 2015;5(1):51–68
India’s first ever 3D Liver App! Free of cost, easy to navigate and user friendly!
This free app enables Health Care Practitioners (HCPs) to educate the patients on different stages of liver diseases with the help of a printed marker.
The prevalence of Non-Alcoholic Fatty Liver Disease (NAFLD) in India is around 9-35%¹. Globally liver disease is one of the leading causes of death.
- First of its kind innovative in clinic awareness tool
- Facilitates doctor patient interaction on NAFLD and enhances interest in the same
- Enables HCPs to guide patients on early detection, diagnosis and management of NAFLD
- Prevents the disease progression and enables the patients to live a healthy and happy life
This app is meant for HCPs and works only by scanning the Marker given by Abbott India Limited representatives to doctors.
Contact Abbott India Limited representative (WH & GI Team) to get the marker for the app to function.
¹ Duseja A, et al. Non-alcoholic Fatty Liver Disease and Metabolic Syndrome—Position Paper of the Indian National Association for the Study of the Liver, Endocrine Society of India, Indian College of Cardiology and Indian Society of Gastroenterology. J CLIN EXP HEPATOL 2015;5(1):51–68
Show More
